In the bone microenvironment, TGF-β is released from bone during bone resorption, then it stimulates breast cancer cells to produce osteolytic factors such as interleukin 11(IL-11) to mediate osteolysis by stimulating osteoclast formation and bone resorption activity [55]. Here, TGFB1 is linked to breast carcinoma.